Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age

J Nordanstig; EG Arslan; A Catarig; K Houlind; B Ludvik; N Rasouli; Harald Sourij; S Thomas; S Verma; M Bonaca

doi:10.1093/eurheartj/ehaf784.3030

Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age

J Nordanstig
, EG Arslan
, A Catarig
, K Houlind
, B Ludvik
, N Rasouli
, Harald Sourij
, S Thomas
, S Verma
, M Bonaca

Klinische Abteilung für Endokrinologie und Diabetologie

Publikation: Beitrag in Fachzeitschrift › Konferenzabstract

Originalsprache	Englisch
Fachzeitschrift	European Heart Journal
DOIs	https://doi.org/10.1093/eurheartj/ehaf784.3030
Publikationsstatus	Veröffentlicht - 2025
Veranstaltung	ESC Congress 2025 together with World Congress of Cardiology - Madrid, Spanien Dauer: 29 Aug. 2025 → 1 Sep. 2025

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Zugriff auf Dokument

10.1093/eurheartj/ehaf784.3030

Andere Dateien und Links

Web of Science

Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age
Nordanstig, J. (Autor*in), Arslan, E. (Autor*in), Catarig, A. (Autor*in), Houlind, K. (Autor*in), Ludvik, B. (Autor*in), Rasouli, N. (Autor*in), Sourij, H. (Autor*in), Thomas, S. (Autor*in), Verma, S. (Autor*in) & Bonaca, M. (Autor*in)
2025
Aktivität: Vortrag oder Poster › Poster

Dieses zitieren

@article{b0c02b0dbf844fb9a227ab8df63a91fa,

title = "Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age",

author = "J Nordanstig and EG Arslan and A Catarig and K Houlind and B Ludvik and N Rasouli and Harald Sourij and S Thomas and S Verma and M Bonaca",

year = "2025",

doi = "10.1093/eurheartj/ehaf784.3030",

language = "English",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

note = "ESC Congress 2025 together with World Congress of Cardiology ; Conference date: 29-08-2025 Through 01-09-2025",

}

TY - JOUR

T1 - Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age

AU - Nordanstig, J

AU - Arslan, EG

AU - Catarig, A

AU - Houlind, K

AU - Ludvik, B

AU - Rasouli, N

AU - Sourij, Harald

AU - Thomas, S

AU - Verma, S

AU - Bonaca, M

PY - 2025

Y1 - 2025

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:1666293900001

U2 - 10.1093/eurheartj/ehaf784.3030

DO - 10.1093/eurheartj/ehaf784.3030

M3 - Conference abstract

SN - 0195-668X

JO - European Heart Journal

JF - European Heart Journal

T2 - ESC Congress 2025 together with World Congress of Cardiology

Y2 - 29 August 2025 through 1 September 2025

ER -

Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age

UN SDGs

Zugriff auf Dokument

Andere Dateien und Links

Aktivitäten

Effect of semaglutide in patients with type 2 diabetes and peripheral artery disease: an analysis of the STRIDE trial stratified by disease severity and age

Dieses zitieren